European medical technology takes steps to create an environment for a thriving industry
This article was originally published in Clinica
Executive Summary
Technological progress in the medtech sector is best facilitated by an appropriate regulatory system, adequate funding of innovative R&D and companies receiving payments for products within reasonable time limits. Eucomed director-general Maurice Wagner expanded on these and other pressing themes in an exclusive interview with Amanda Maxwell at the association's impressive new offices in Brussels